Last Updated: November, 2025
Trusted by 200+ Clients
The report provides a detailed analysis essential for establishing an Idarubicin production plant. It encompasses all critical aspects necessary for Idarubicin production, including the cost of Idarubicin production, Idarubicin plant cost, Idarubicin production costs, and the overall Idarubicin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Idarubicin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Idarubicin is a chemotherapy drug primarily used in the treatment of various types of cancer, particularly leukaemia and lymphoma. It is used in the treatment of acute myeloid leukaemia (AML) and other hematologic cancers. It also finds its application as a drug used in combination with other chemotherapy medications to increase its effectiveness in treating cancer. It is an anthracycline antibiotic that works by interfering with the DNA inside cancer cells, which prevents them from growing and dividing. In addition to its use in cancer treatment, idarubicin is also being studied for its potential in treating other solid tumours. It is also sometimes used in the treatment of breast cancer and other malignancies.
The market for Idarubicin is primarily driven by its significant role in the treatment of various cancers, particularly leukaemia and lymphoma, which boosts its demand in the pharmaceutical and oncology sectors. Its application as an anthracycline chemotherapy drug for inhibiting cancer cell growth in combination cancer treatments also fuels its demand in the medical and pharmaceutical industries. Its involvement as a chemotherapy drug in the treatment of both acute myeloid leukaemia (AML) and other hematologic cancers further strengthens its demand in the oncology market.
Additionally, the growing use of Idarubicin in clinical trials for other types of cancer also increases its market expansion. Factors such as the cost of production, availability of raw materials, adherence to strict pharmaceutical regulations, and maintaining high-quality standards significantly impact industrial Idarubicin procurement globally. Moreover, advancements in drug delivery technologies, increased focus on the efficiency of cancer treatments, and optimised distribution networks also enhance procurement processes.
According to the Idarubicin production plant project report, the major raw materials for Idarubicin production include 3'-Prot-daunorubicin – Lewis Acid.
The extensive Idarubicin production cost report consists of the following industrial production process:
Idarubicin is an anthracycline chemotherapy drug used in the treatment of various cancers, including leukaemia and breast cancer. It appears as a red to orange crystalline powder with a characteristic odour. Its molecular formula is C26H27NO9, and its molecular weight is 527.5 g/mol. Idarubicin has a density of approximately 1.35 g/cm³. The compound is soluble in methanol and dimethyl sulfoxide (DMSO), but it is poorly soluble in water. The melting point of Idarubicin is around 210-212 degree Celsius. Idarubicin works by intercalating into DNA and inhibiting topoisomerase II, which ultimately prevents DNA replication and induces cell death. Proper handling precautions, including protective clothing and gloves, should be used to minimise exposure, as it is a potent cytotoxic agent. The drug can cause significant side effects, including cardiotoxicity, and should be administered under strict medical supervision.
Idarubicin Production Cost Report
Choose What's Right for You
Pay Via
| Particulars | Details |
|---|---|
| Product Name | Idarubicin |
| Scope | Production Process: Process Flow, Material Flow, Material Balance Raw Material and Product Specifications: Raw Material Consumption, Product and Co-product Generation Land and Site Cost: Offsites/Civil Works, Equipment Cost, Auxiliary Equipment Costs, Contingency, Engineering and Consulting Charges, Working Capital Variable Cost: Raw Material, Utilities, Other Variable Costs Fixed Cost: Labor Requirements and Wages, Overhead Expenses, Maintenance Charges, Other Fixed Costs Financing Costs: Interest on Working Capital, Interest on Loans Other Costs: Depreciation Charges, General Sales and Admin Cost |
| Currency | US$ (Data can also be provided in the local currency) | Customization Scope | The report can be customized as per the requirement of the customer |
| Post-Sale Analysts Report | 10-12 weeks of post-purchase analyst support after report delivery for any queries from the deliverable |
| Delivery Format | PDF and Excel format through email (editable version in PPT/Word format of the report can be also provided on special request) |
At Procurement Resource, we not only focus on optimizing the should cost of production for Idarubicin but also provide our clients with extensive intel and rigorous information on every aspect of the production process. By utilizing a comprehensive cost model, we help you break down expenses related to raw materials, labor, and technology, offering clear pathways to savings. We also assist in evaluating the capital expenditure (CAPEX) and operating expenses (OPEX), which are often measured as cost per unit of production, such as USD/MT, ensuring that your financial planning is aligned with industry benchmarks.
We offer valuable insights on the top technology providers, in-depth supplier database, and best manufacturers, helping you make informed decisions to improve efficiency. Additionally, we design the most feasible layout for your production needs, ensuring the entire process runs smoothly. By minimizing the cash cost of production, we ensure that you stay competitive while securing long-term profitability in the growing Idarubicin market. Partnering with Procurement Resource guarantees that every aspect of your production is cost-efficient, advanced, and tailored to your specific requirements.
Lead - Social & Development Research
Delivering procurement intelligence and supply chain analytics across healthcare, FMCG, and chemicals sectors, with expertise in cost modeling, vendor mapping, and spend optimization to support data-driven sourcing decisions and procurement outcomes.
Need more help?
Still Need Help?
Compare & Choose the Right Report Version for You
How to Order Your Report?
